Chris Garabedian - President and Chief Executive Officer
I know I am not going to give the number, I don’t give the numbers. So but here is what I would say, we at Sarepta, who have looked at this data from day one with a critical eye have believed that there is a real effect here biochemically, clinically and we are very pleased with the safety profile. So from the beginning when we submitted that first briefing document on the 48 week data back in February of 2013 we were confident that this might warrant being looked at that for an accelerated approval, okay. We have only seen our confidence increase as we have gotten more and more updates on the clinical and safety outcome parameters. Our confidence in our dataset has increased even further now that we spend the last six months really talking to a lot of experts in the field, these are experts in natural history, they are experts in dystrophin, they are experts in pulmonary function, they are just practicing clinicians who see a lot of Duchene and the more we share our dataset with them and get their feedback, what do they think, that gives us even more confidence that our view on the dataset is the right one that this drug is working.
So our confidence level, I would say, has increased over the time as the data has held up and I would say given the recent FDA communications, I am confident that there is more of an understanding on the FDA's part of this disease of how we conducted the study, of the expert opinions, they have talked to some of the experts directly themselves. And so I think overall, my confidence level has increased over that period, over the last year because of additional data, additional perspectives from experts.
Sentiment: Strong Buy
"Who do you think you are?"... If he is honest - the answer should be a such: " I am a paid by pharmaceuticals callow chemist (or his wife), and I'm here to doubt the truth by all available pseudo-scientific gibberish in order to #$%$ and confuse naive investors, fooling them into selling their shares.... Also I was discharged by the Sarepta."
Sentiment: Strong Buy
Who are the buyers of these sold shares? I don't think all the sold shares are bought by new investors or retail investors. All the institutions are smart money so please tell us who are the buyers of these shares when everybody knows it is going down. Most of the retail will buy when the stocks go up and sell when the markets go down due greed and panic respectively. So in this case if Smart money is selling and retail also selling due to panic and margin calls, then please tell us who are the buyers of these sold shares or who are the smart money selling to?
It the same people buying and selling. They keep all this stuff in inventory. They have deep pockets, and you got the Fed and this US Government keeping them liquid. YOU, the person looking at your screen, is SUPPOSE to believe that the good 'ol market maker is matching buyers with sellers. But what is REALLY happening is the market makers take stock prices up and down according to whatever insider information they have, and you are suppose to believe what the media tells you. Their goal is simple. Get you to buy hype, or sell fear. So long as you buy too high or sell into losses, they are making money.
Unparalleled mix of pain and love, hope and despair in this breath taking visuals of unlawful FDA confronted by the parents of the dying boys. Crime must be punished. Allowing death by preventing an access to the heeling drug must be regarded as an intention to kill.
She is a dinosaur by knowledge, a snake by the intend and angry and deceptive like a rat. Monster has a power to prevent boys from healing. What a country!
Good to hear from you, Christine. Let's believe that you soon will have plenty of time to spend with your both boys.
Favoring her husband investment into the drug that is in competition with the drug under her approval is not only unethical conflict of interests - that is a pure CRIME.
Eyes closed, ears corked and brains are rusty. Mute, deaf and blind. Diminishing shallow breathing. Near death?